{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:45:40Z","timestamp":1790484340909,"version":"4.1.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/nrneph.2015.153","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T05:47:01Z","timestamp":1443505621000},"page":"656-666","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Phosphate and FGF-23 homeostasis after kidney transplantation"],"prefix":"10.1038","volume":"11","author":[{"name":"for the NIGRAM investigators","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro C.","family":"Baia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ita Pfeferman","family":"Heilberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerjan","family":"Navis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"de Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,29]]},"reference":[{"key":"BFnrneph2015153_CR1","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova, T. et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 79, 1370\u20131378 (2011).","journal-title":"Kidney Int."},{"key":"BFnrneph2015153_CR2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrneph.2013.147","volume":"9","author":"J Silver","year":"2013","unstructured":"Silver, J. & Naveh-Many, T. FGF-23 and secondary hyperparathyroidism in chronic kidney disease. Nat. Rev. Nephrol. 9, 641\u2013649 (2013).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph2015153_CR3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrneph.2014.49","volume":"10","author":"JJ Scialla","year":"2014","unstructured":"Scialla, J. J. & Wolf, M. Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nat. Rev. Nephrol. 10, 268\u2013278 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph2015153_CR4","doi-asserted-by":"publisher","unstructured":"Wolf, M. et al. A prospective cohort study of mineral metabolism after kidney transplantation. Transplantation http:\/\/dx.doi.org\/10.1097\/TP.0000000000000823 .","DOI":"10.1097\/TP.0000000000000823"},{"key":"BFnrneph2015153_CR5","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/clinchem\/34.8.1622","volume":"34","author":"G Lockitch","year":"1988","unstructured":"Lockitch, G., Halstead, A. C., Albersheim, S., MacCallum, C. & Quigley, G. Age- and sex-specific paediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyzer. Clin. Chem. 34, 1622\u20131625 (1988).","journal-title":"Clin. Chem."},{"key":"BFnrneph2015153_CR6","doi-asserted-by":"crossref","first-page":"14564","DOI":"10.1073\/pnas.95.24.14564","volume":"95","author":"H Hilfiker","year":"1998","unstructured":"Hilfiker, H. et al. Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc. Natl Acad. Sci. USA 95, 14564\u201314569 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2015153_CR7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00658486","volume":"388","author":"G Danisi","year":"1980","unstructured":"Danisi, G., Bonjour, J. P. & Straub, R. W. Regulation of Na-dependent phosphate influx across the mucosal border of duodenum by 1, 25-dihydroxycholecalciferol. Pflugers Arch. 388, 227\u2013232 (1980).","journal-title":"Pflugers Arch."},{"key":"BFnrneph2015153_CR8","first-page":"G756","volume":"277","author":"O Hattenhauer","year":"1999","unstructured":"Hattenhauer, O., Traebert, M., Murer, H. & Biber, J. Regulation of small intestinal Na-P(i) type IIb cotransporter by dietary phosphate intake. Am. J. Physiol. 277, G756\u2013G762 (1999).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph2015153_CR9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrneph.2010.121","volume":"6","author":"AS Alizadeh Naderi","year":"2010","unstructured":"Alizadeh Naderi, A. S. & Reilly, R. F. Hereditary disorders of renal phosphate wasting. Nat. Rev. Nephrol. 6, 657\u2013665 (2010).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph2015153_CR10","doi-asserted-by":"crossref","first-page":"F643","DOI":"10.1152\/ajprenal.00228.2007","volume":"293","author":"LV Virkki","year":"2007","unstructured":"Virkki, L. V., Biber, J., Murer, H. & Forster, I. C. Phosphate transporters: a tale of two solute carrier families. Am. J. Physiol. Renal Physiol. 293, F643\u2013654 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"Suppl. 1","key":"BFnrneph2015153_CR11","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.bone.2009.02.003","volume":"45","author":"H Segawa","year":"2009","unstructured":"Segawa, H., Aranami, F., Kaneko, I., Tomoe, Y. & Miyamoto, K. The roles of Na\/Pi-II transporters in phosphate metabolism. Bone 45 (Suppl. 1), S2\u2013S7 (2009).","journal-title":"Bone"},{"key":"BFnrneph2015153_CR12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada, T. et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 19, 429\u2013435 (2004).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph2015153_CR13","doi-asserted-by":"crossref","first-page":"F1341","DOI":"10.1152\/ajprenal.00375.2009","volume":"298","author":"Y Tomoe","year":"2010","unstructured":"Tomoe, Y. et al. Phosphaturic action of fibroblast growth factor 23 in Npt2 null mice. Am. J. Physiol. Renal Physiol. 298, F1341\u2013F1350 (2010).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2015153_CR14","doi-asserted-by":"crossref","first-page":"37216","DOI":"10.1074\/jbc.M111.288357","volume":"286","author":"EJ Weinman","year":"2011","unstructured":"Weinman, E. J., Steplock, D., Shenolikar, S. & Biswas, R. Fibroblast growth factor-23-mediated inhibition of renal phosphate transport in mice requires sodium-hydrogen exchanger regulatory factor-1 (NHERF-1) and synergizes with parathyroid hormone. J. Biol. Chem. 286, 37216\u201337221 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2015153_CR15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI3208","volume":"104","author":"M Lotscher","year":"1999","unstructured":"Lotscher, M. et al. Rapid downregulation of rat renal Na\/P(i) cotransporter in response to parathyroid hormone involves microtubule rearrangement. J. Clin. Invest. 104, 483\u2013494 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2015153_CR16","doi-asserted-by":"crossref","first-page":"20125","DOI":"10.1074\/jbc.272.32.20125","volume":"272","author":"MF Pfister","year":"1997","unstructured":"Pfister, M. F. et al. Parathyroid hormone-dependent degradation of type II Na+\/Pi cotransporters. J. Biol. Chem. 272, 20125\u201320130 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnrneph2015153_CR17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada, T. et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113, 561\u2013568 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2015153_CR18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","volume":"82","author":"M Wolf","year":"2012","unstructured":"Wolf, M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int. 82, 737\u2013747 (2012).","journal-title":"Kidney Int."},{"key":"BFnrneph2015153_CR19","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1172\/JCI103042","volume":"33","author":"R Goldman","year":"1954","unstructured":"Goldman, R. & Bassett, S. H. Phosphorus excretion in renal failure. J. Clin. Invest. 33, 1623\u20131628 (1954).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2015153_CR20","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","volume":"78","author":"H Hasegawa","year":"2010","unstructured":"Hasegawa, H. et al. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int. 78, 975\u2013980 (2010).","journal-title":"Kidney Int."},{"key":"BFnrneph2015153_CR21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-physiol-030212-183727","volume":"75","author":"MC Hu","year":"2013","unstructured":"Hu, M. C., Shiizaki, K., Kuro-o, M. & Moe, O. W. Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu. Rev. Physiol. 75, 503\u2013533 (2013).","journal-title":"Annu. Rev. Physiol."},{"key":"BFnrneph2015153_CR22","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1046\/j.1523-1755.2001.0600031182.x","volume":"60","author":"J Green","year":"2001","unstructured":"Green, J. et al. Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphataemia and phosphaturia. Kidney Int. 60, 1182\u20131196 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph2015153_CR23","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2215\/CJN.01310308","volume":"3","author":"P Evenepoel","year":"2008","unstructured":"Evenepoel, P. et al. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin. J. Am. Soc. Nephrol. 3, 1829\u20131836 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR24","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1530\/EJE-10-1150","volume":"164","author":"A Trombetti","year":"2011","unstructured":"Trombetti, A. et al. Early post-transplantation hypophosphataemia is associated with elevated FGF-23 levels. Eur. J. Endocrinol. 164, 839\u2013847 (2011).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrneph2015153_CR25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.transproceed.2011.11.046","volume":"44","author":"SY Han","year":"2012","unstructured":"Han, S. Y., Hwang, E. A., Park, S. B., Kim, H. C. & Kim, H. T. Elevated fibroblast growth factor 23 levels as a cause of early post-renal transplantation hypophosphataemia. Transplant. Proc. 44, 657\u2013660 (2012).","journal-title":"Transplant. Proc."},{"key":"BFnrneph2015153_CR26","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1600-6143.2007.01753.x","volume":"7","author":"P Evenepoel","year":"2007","unstructured":"Evenepoel, P., Naesens, M., Claes, K., Kuypers, D. & Vanrenterghem, Y. Tertiary 'hyperphosphatoninism' accentuates hypophosphataemia and suppresses calcitriol levels in renal transplant recipients. Am. J. Transplant. 7, 1193\u20131200 (2007).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2015153_CR27","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1093\/ndt\/gfl201","volume":"21","author":"NC Boudville","year":"2006","unstructured":"Boudville, N. C. & Hodsman, A. B. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients. Nephrol. Dial. Transplant. 21, 2621\u20132624 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1530\/EJE-10-1150","volume":"164","author":"A Trombetti","year":"2011","unstructured":"Trombetti, A. et al. Early post-transplantation hypophosphataemia is associated with elevated FGF-23 levels. Eur. J. Endocrinol. 164, 839\u2013847 (2011).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrneph2015153_CR29","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1093\/ndt\/gfq777","volume":"26","author":"H Kawarazaki","year":"2011","unstructured":"Kawarazaki, H. et al. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphataemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study. Nephrol. Dial. Transplant. 26, 2691\u20132695 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR30","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00467-013-2547-z","volume":"28","author":"K Wesseling-Perry","year":"2013","unstructured":"Wesseling-Perry, K. et al. FGF23 and mineral metabolism in the early post-renal transplantation period. Pediatr. Nephrol. 28, 2207\u20132215 (2013).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2015153_CR31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/ndt\/5.1.62","volume":"5","author":"RM Higgins","year":"1990","unstructured":"Higgins, R. M., Richardson, A. J., Endre, Z. H., Frostick, S. P. & Morris, P. J. Hypophosphataemia after renal transplantation: relationship to immunosuppressive drug therapy and effects on muscle detected by 31P nuclear magnetic resonance spectroscopy. Nephrol. Dial. Transplant. 5, 62\u201368 (1990).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR32","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.V991560","volume":"9","author":"J Loffing","year":"1998","unstructured":"Loffing, J. et al. Renal Na\/H exchanger NHE-3 and Na-PO4 cotransporter NaPi-2 protein expression in glucocorticoid excess and deficient states. J. Am. Soc. Nephrol. 9, 1560\u20131567 (1998).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1172\/JCI118022","volume":"96","author":"M Levi","year":"1995","unstructured":"Levi, M. et al. Dexamethasone modulates rat renal brush border membrane phosphate transporter mRNA and protein abundance and glycosphingolipid composition. J. Clin. Invest. 96, 207\u2013216 (1995).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2015153_CR34","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/jn\/122.6.1273","volume":"122","author":"SM Borowitz","year":"1992","unstructured":"Borowitz, S. M. & Granrud, G. S. Glucocorticoids inhibit intestinal phosphate absorption in developing rabbits. J. Nutr. 122, 1273\u20131279 (1992).","journal-title":"J. Nutr."},{"key":"BFnrneph2015153_CR35","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM198912213212507","volume":"321","author":"BD Kahan","year":"1989","unstructured":"Kahan, B. D. Cyclosporine. N. Engl. J. Med. 321, 1725\u20131738 (1989).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2015153_CR36","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1097\/01.ASN.0000144207.44469.BE","volume":"15","author":"Y Moz","year":"2004","unstructured":"Moz, Y. et al. Calcineurin Abeta is central to the expression of the renal type II Na\/Pi co-transporter gene and to the regulation of renal phosphate transport. J. Am. Soc. Nephrol. 15, 2972\u20132980 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR37","first-page":"F518","volume":"260","author":"M Demeule","year":"1991","unstructured":"Demeule, M. & Beliveau, R. Cyclosporin inhibits phosphate transport and stimulates alkaline phosphatase activity in renal BBMV. Am. J. Physiol. 260, F518\u2013524 (1991).","journal-title":"Am. J. Physiol."},{"key":"BFnrneph2015153_CR38","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0002-9343(86)90292-5","volume":"81","author":"AG Palestine","year":"1986","unstructured":"Palestine, A. G., Austin, H. A. 3rd & Nussenblatt, R. B. Renal tubular function in cyclosporine-treated patients. Am. J. Med. 81, 419\u2013424 (1986).","journal-title":"Am. J. Med."},{"key":"BFnrneph2015153_CR39","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/ndt\/gfq172","volume":"25","author":"DS Kempe","year":"2010","unstructured":"Kempe, D. S. et al. Rapamycin-induced phosphaturia. Nephrol. Dial. Transplant. 25, 2938\u20132944 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ndt\/16.2.378","volume":"16","author":"C Schwarz","year":"2001","unstructured":"Schwarz, C., Bohmig, G. A., Steininger, R., Mayer, G. & Oberbauer, R. Impaired phosphate handling of renal allografts is aggravated under rapamycin-based immunosuppression. Nephrol. Dial. Transplant. 16, 378\u2013382 (2001).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR41","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1200\/JCO.2008.16.7858","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao, J. C. et al. Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study. J. Clin. Oncol. 26, 4311\u20134318 (2008).","journal-title":"J. Clin. Oncol."},{"key":"BFnrneph2015153_CR42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1470-2045(14)71136-2","volume":"16","author":"G Grignani","year":"2015","unstructured":"Grignani, G. et al. Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial. Lancet Oncol. 16, 98\u2013107 (2015).","journal-title":"Lancet Oncol."},{"key":"BFnrneph2015153_CR43","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1600-6143.2011.03590.x","volume":"11","author":"T Tataranni","year":"2011","unstructured":"Tataranni, T. et al. Rapamycin-induced hypophosphataemia and insulin resistance are associated with mTORC2 activation and Klotho expression. Am. J. Transplant. 11, 1656\u20131664 (2011).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2015153_CR44","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00424-008-0530-5","volume":"457","author":"M Nowik","year":"2008","unstructured":"Nowik, M. et al. Renal phosphaturia during metabolic acidosis revisited: molecular mechanisms for decreased renal phosphate reabsorption. Pflugers Arch. 457, 539\u2013549 (2008).","journal-title":"Pflugers Arch."},{"key":"BFnrneph2015153_CR45","doi-asserted-by":"crossref","first-page":"F925","DOI":"10.1152\/ajprenal.2000.278.6.F925","volume":"278","author":"TH Kwon","year":"2000","unstructured":"Kwon, T. H., Frokiaer, J., Han, J. S., Knepper, M. A. & Nielsen, S. Decreased abundance of major Na(+) transporters in kidneys of rats with ischemia-induced acute renal failure. Am. J. Physiol. Renal Physiol. 278, F925\u2013939 (2000).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2015153_CR46","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1073\/pnas.71.4.1040","volume":"71","author":"Y Tanaka","year":"1974","unstructured":"Tanaka, Y. et al. Role of 1, 25-dihydroxyvitamin D3 in maintaining serum phosphorus and curing rickets. Proc. Natl. Acad. Sci. USA 71, 1040\u20131044 (1974).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnrneph2015153_CR47","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/bmj.1.6165.712","volume":"1","author":"K Farrington","year":"1979","unstructured":"Farrington, K. et al. Dissociation of absorptions of calcium and phosphate after successful cadaveric renal transplantation. Br. Med. J. 1, 712\u2013714 (1979).","journal-title":"Br. Med. J."},{"key":"BFnrneph2015153_CR48","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0140-6736(74)92902-X","volume":"1","author":"JF Moorhead","year":"1974","unstructured":"Moorhead, J. F. et al. Hypophosphataemic osteomalacia after cadaveric renal transplantation. Lancet 1, 694\u2013697 (1974).","journal-title":"Lancet"},{"key":"BFnrneph2015153_CR49","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ki.1981.54","volume":"19","author":"RW Rosenbaum","year":"1981","unstructured":"Rosenbaum, R. W., Hruska, K. A., Korkor, A., Anderson, C. & Slatopolsky, E. Decreased phosphate reabsorption after renal transplantation: Evidence for a mechanism independent of calcium and parathyroid hormone. Kidney Int. 19, 568\u2013578 (1981).","journal-title":"Kidney Int."},{"key":"BFnrneph2015153_CR50","first-page":"333","volume":"12","author":"AJ Felsenfeld","year":"1986","unstructured":"Felsenfeld, A. J., Gutman, R. A., Drezner, M. & Llach, F. Hypophosphataemia in long-term renal transplant recipients: effects on bone histology and 1, 25-dihydroxycholecalciferol. Miner. Electrolyte Metab. 12, 333\u2013341 (1986).","journal-title":"Miner. Electrolyte Metab."},{"key":"BFnrneph2015153_CR51","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1046\/j.1523-1755.2001.00755.x","volume":"59","author":"M Levi","year":"2001","unstructured":"Levi, M. Post-transplant hypophosphataemia. Kidney Int. 59, 2377\u20132387 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph2015153_CR52","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.2009121293","volume":"21","author":"M Wolf","year":"2010","unstructured":"Wolf, M. Forging forward with 10 burning questions on FGF23 in kidney disease. J. Am. Soc. Nephrol. 21, 1427\u20131435 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR53","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1093\/ndt\/gfr126","volume":"26","author":"K Wesseling-Perry","year":"2011","unstructured":"Wesseling-Perry, K., Tsai, E. W., Ettenger, R. B., Juppner, H. & Salusky, I. B. Mineral abnormalities and long-term graft function in paediatric renal transplant recipients: a role for FGF-23? Nephrol. Dial. Transplant. 26, 3779\u20133784 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR54","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bone.2012.06.027","volume":"51","author":"K Tomida","year":"2012","unstructured":"Tomida, K. et al. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation. Bone 51, 729\u2013736 (2012).","journal-title":"Bone"},{"key":"BFnrneph2015153_CR55","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2009-1576","volume":"95","author":"J Bacchetta","year":"2010","unstructured":"Bacchetta, J. et al. The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in paediatric chronic kidney disease. J. Clin. Endocrinol. Metab. 95, 1741\u20131748 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneph2015153_CR56","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1093\/ndt\/gfs409","volume":"27","author":"AI Sanchez Fructuoso","year":"2012","unstructured":"Sanchez Fructuoso, A. I. et al. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients. Nephrol. Dial. Transplant. 27, 4227\u20134235 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/MNH.0b013e32836213ee","volume":"22","author":"H Olauson","year":"2013","unstructured":"Olauson, H. & Larsson, T. E. FGF23 and Klotho in chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 22, 397\u2013404 (2013).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrneph2015153_CR58","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.RES.0000216409.20863.e7","volume":"98","author":"X Li","year":"2006","unstructured":"Li, X., Yang, H. Y. & Giachelli, C. M. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ. Res. 98, 905\u2013912 (2006).","journal-title":"Circ. Res."},{"key":"BFnrneph2015153_CR59","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","volume":"87","author":"S Jono","year":"2000","unstructured":"Jono, S. et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ. Res. 87, E10\u201317 (2000).","journal-title":"Circ. Res."},{"key":"BFnrneph2015153_CR60","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.RES.84.2.166","volume":"84","author":"T Wada","year":"1999","unstructured":"Wada, T., McKee, M. D., Steitz, S. & Giachelli, C. M. Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ. Res. 84, 166\u2013178 (1999).","journal-title":"Circ. Res."},{"key":"BFnrneph2015153_CR61","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2013.3","volume":"83","author":"JJ Scialla","year":"2013","unstructured":"Scialla, J. J. et al. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int. 83, 1159\u20131168 (2013).","journal-title":"Kidney Int."},{"key":"BFnrneph2015153_CR62","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2013050465","volume":"25","author":"JJ Scialla","year":"2014","unstructured":"Scialla, J. J. et al. Fibroblast growth factor-23 and cardiovascular events in CKD. J. Am. Soc. Nephrol. 25, 349\u2013360 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.ajkd.2014.07.022","volume":"65","author":"JK Humalda","year":"2015","unstructured":"Humalda, J. K. et al. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade. Am. J. Kidney Dis. 65, 259\u2013266 (2015).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2015153_CR64","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/emmm.201303716","volume":"5","author":"O Andrukhova","year":"2014","unstructured":"Andrukhova, O. et al. FGF23 regulates renal sodium handling and blood pressure. EMBO Mol. Med. 5, 744\u2013759 (2014).","journal-title":"EMBO Mol. Med."},{"key":"BFnrneph2015153_CR65","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","volume":"108","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak, M. J. et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108, 2154\u20132169 (2003).","journal-title":"Circulation"},{"key":"BFnrneph2015153_CR66","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/j.ajkd.2011.07.019","volume":"59","author":"C Marechal","year":"2012","unstructured":"Marechal, C. et al. Progression of coronary artery calcification and thoracic aorta calcification in kidney transplant recipients. Am. J. Kidney Dis. 59, 258\u2013269 (2012).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2015153_CR67","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/ndt\/gfn753","volume":"24","author":"SS DeLoach","year":"2009","unstructured":"DeLoach, S. S., Joffe, M. M., Mai, X., Goral, S. & Rosas, S. E. Aortic calcification predicts cardiovascular events and all-cause mortality in renal transplantation. Nephrol. Dial. Transplant. 24, 1314\u20131319 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR68","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/ATVBAHA.113.302070","volume":"34","author":"LL Demer","year":"2014","unstructured":"Demer, L. L. & Tintut, Y. Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler. Thromb. Vasc. Biol. 34, 715\u2013723 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrneph2015153_CR69","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000362492","volume":"39","author":"G Cianciolo","year":"2014","unstructured":"Cianciolo, G. et al. Importance of vascular calcification in kidney transplant recipients. Am. J. Nephrol. 39, 418\u2013426 (2014).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph2015153_CR70","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1053\/j.ajkd.2013.05.025","volume":"62","author":"G Cianciolo","year":"2013","unstructured":"Cianciolo, G., Scolari, M. P., Angelini, M. L. & Stefoni, S. Progression of vascular calcification in kidney transplantation: the need to assess the calcium burden and to understand why some patients have a calcium score of 0. Am. J. Kidney Dis. 62, 644\u2013645 (2013).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2015153_CR71","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1681\/ASN.2012030240","volume":"23","author":"A Pasch","year":"2012","unstructured":"Pasch, A. et al. Nanoparticle-based test measures overall propensity for calcification in serum. J. Am. Soc. Nephrol. 23, 1744\u20131752 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR72","doi-asserted-by":"publisher","unstructured":"Keyzer, C. A. et al. Calcification propensity and survival among renal transplant recipients. J. Am. Soc. Nephrol. http:\/\/dx.doi.org\/10.1681\/ASN.2014070670 .","DOI":"10.1681\/ASN.2014070670"},{"key":"BFnrneph2015153_CR73","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/TP.0b013e31819cd122","volume":"87","author":"GM Connolly","year":"2009","unstructured":"Connolly, G. M., Cunningham, R., McNamee, P. T., Young, I. S. & Maxwell, A. P. Elevated serum phosphate predicts mortality in renal transplant recipients. Transplantation 87, 1040\u20131044 (2009).","journal-title":"Transplantation"},{"key":"BFnrneph2015153_CR74","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","volume":"22","author":"M Wolf","year":"2011","unstructured":"Wolf, M. et al. Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J. Am. Soc. Nephrol. 22, 956\u2013966 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR75","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.2215\/CJN.01880213","volume":"8","author":"LC Baia","year":"2013","unstructured":"Baia, L. C. et al. Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation. Clin. J. Am. Soc. Nephrol. 8, 1968\u20131978 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR76","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.transproceed.2014.09.015","volume":"46","author":"J Malyszko","year":"2014","unstructured":"Malyszko, J., Koc-Zorawska, E., Matuszkiewicz-Rowinska, J. & Malyszko, J. FGF23 and Klotho in relation to markers of endothelial dysfunction in kidney transplant recipients. Transplant. Proc. 46, 2647\u20132650 (2014).","journal-title":"Transplant. Proc."},{"key":"BFnrneph2015153_CR77","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000346711","volume":"37","author":"MI Yilmaz","year":"2013","unstructured":"Yilmaz, M. I. et al. Longitudinal analysis of vascular function and biomarkers of metabolic bone disorders before and after renal transplantation. Am. J. Nephrol. 37, 126\u2013134 (2013).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph2015153_CR78","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.transproceed.2013.10.043","volume":"46","author":"E Asicioglu","year":"2014","unstructured":"Asicioglu, E. et al. Fibroblast growth factor-23 levels are associated with uric acid but not carotid intima media thickness in renal transplant recipients. Transplant. Proc. 46, 180\u2013183 (2014).","journal-title":"Transplant. Proc."},{"key":"BFnrneph2015153_CR79","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/0886022X.2012.734890","volume":"35","author":"O Gungor","year":"2013","unstructured":"Gungor, O. et al. The relationships between serum sTWEAK, FGF-23 levels, and carotid atherosclerosis in renal transplant patients. Ren. Fail. 35, 77\u201381 (2013).","journal-title":"Ren. Fail."},{"key":"BFnrneph2015153_CR80","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1681\/ASN.2011111115","volume":"23","author":"MM Mitsnefes","year":"2012","unstructured":"Mitsnefes, M. M. Cardiovascular disease in children with chronic kidney disease. J. Am. Soc. Nephrol. 23, 578\u2013585 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR81","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.1980.85","volume":"17","author":"LL Haut","year":"1980","unstructured":"Haut, L. L., Alfrey, A. C., Guggenheim, S., Buddington, B. & Schrier, N. Renal toxicity of phosphate in rats. Kidney Int. 17, 722\u2013731 (1980).","journal-title":"Kidney Int."},{"key":"BFnrneph2015153_CR82","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1084\/jem.61.3.319","volume":"61","author":"EM Mackay","year":"1935","unstructured":"Mackay, E. M. & Oliver, J. Renal damage following the ingestion of a diet containing an excess of inorganic phosphate. J. Exp. Med. 61, 319\u2013334 (1935).","journal-title":"J. Exp. Med."},{"key":"BFnrneph2015153_CR83","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","volume":"18","author":"D Fliser","year":"2007","unstructured":"Fliser, D. et al. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J. Am. Soc. Nephrol. 18, 2600\u20132608 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR84","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.10331011","volume":"7","author":"S Lundberg","year":"2012","unstructured":"Lundberg, S. et al. FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy. Clin. J. Am. Soc. Nephrol. 7, 727\u2013734 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR85","doi-asserted-by":"crossref","first-page":"119","DOI":"10.6002\/ect.2011.0110","volume":"10","author":"D Benavente","year":"2012","unstructured":"Benavente, D. et al. Serum phosphate measured at 6 and 12 months after successful kidney transplant is independently associated with subsequent graft loss. Exp. Clin. Transplant. 10, 119\u2013124 (2012).","journal-title":"Exp. Clin. Transplant."},{"key":"BFnrneph2015153_CR86","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2215\/CJN.06200614","volume":"10","author":"M Bonthuis","year":"2015","unstructured":"Bonthuis, M. et al. Mineral metabolism in European children living with a renal transplant: a European Society for Paediatric Nephrology\/European Renal Association-European Dialysis and Transplant Association Registry Study. Clin. J. Am. Soc. Nephrol. 10, 767\u2013775 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR87","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1399-0012.2007.00690.x","volume":"21","author":"OI Egbuna","year":"2007","unstructured":"Egbuna, O. I., Taylor, J. G., Bushinsky, D. A. & Zand, M. S. Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure. Clin. Transplant. 21, 558\u2013566 (2007).","journal-title":"Clin. Transplant."},{"key":"BFnrneph2015153_CR88","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.2215\/CJN.01880213","volume":"8","author":"LC Baia","year":"2013","unstructured":"Baia, L. C. et al. Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation. Clin. J. Am. Soc. Nephrol. 8, 1968\u20131978 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR89","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/ajt.12738","volume":"14","author":"R McGregor","year":"2014","unstructured":"McGregor, R. et al. Vitamin D in renal transplantation - from biological mechanisms to clinical benefits. Am. J. Transplant. 14, 1259\u20131270 (2014).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2015153_CR90","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1681\/ASN.2012060614","volume":"24","author":"F Bienaime","year":"2013","unstructured":"Bienaime, F. et al. Vitamin D status and outcomes after renal transplantation. J. Am. Soc. Nephrol. 24, 831\u2013841 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR91","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/jc.2013-2421","volume":"99","author":"Y Obi","year":"2014","unstructured":"Obi, Y. et al. Vitamin D deficiency predicts decline in kidney allograft function: a prospective cohort study. J. Clin. Endocrinol. Metab. 99, 527\u2013535 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneph2015153_CR92","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/jc.2014-3012","volume":"100","author":"CA Keyzer","year":"2015","unstructured":"Keyzer, C. A. et al. Associations of 25(OH) and 1, 25(OH)2 vitamin D with long-term outcomes in stable renal transplant recipients. J. Clin. Endocrinol. Metab. 100, 81\u201389 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneph2015153_CR93","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2215\/CJN.01510506","volume":"1","author":"JR Weisinger","year":"2006","unstructured":"Weisinger, J. R., Carlini, R. G., Rojas, E. & Bellorin-Font, E. Bone disease after renal transplantation. Clin. J. Am. Soc. Nephrol. 1, 1300\u20131313 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR94","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1046\/j.1523-1755.1998.00866.x","volume":"53","author":"CP Sanchez","year":"1998","unstructured":"Sanchez, C. P. et al. Bone disease in children and adolescents undergoing successful renal transplantation. Kidney Int. 53, 1358\u20131364 (1998).","journal-title":"Kidney Int."},{"key":"BFnrneph2015153_CR95","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2215\/CJN.03770609","volume":"5","author":"R Mainra","year":"2010","unstructured":"Mainra, R. & Elder, G. J. Individualized therapy to prevent bone mineral density loss after kidney and kidney\u2013pancreas transplantation. Clin. J. Am. Soc. Nephrol. 5, 117\u2013124 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR96","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1046\/j.1523-1755.2003.00938.x","volume":"63","author":"E Rojas","year":"2003","unstructured":"Rojas, E. et al. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int. 63, 1915\u20131923 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph2015153_CR97","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.mnh.0000203187.49890.cc","volume":"15","author":"H Ghanekar","year":"2006","unstructured":"Ghanekar, H., Welch, B. J., Moe, O. W. & Sakhaee, K. Post-renal transplantation hypophosphataemia: a review and novel insights. Curr. Opin. Nephrol. Hypertens. 15, 97\u2013104 (2006).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrneph2015153_CR98","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2215\/CJN.00950110","volume":"5","author":"N Kanaan","year":"2010","unstructured":"Kanaan, N. et al. Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss. Clin. J. Am. Soc. Nephrol. 5, 1887\u20131892 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR99","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.V1161093","volume":"11","author":"MC Monier-Faugere","year":"2000","unstructured":"Monier-Faugere, M. C., Mawad, H., Qi, Q., Friedler, R. M. & Malluche, H. H. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J. Am. Soc. Nephrol. 11, 1093\u20131099 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1399-3046.2010.01405.x","volume":"15","author":"W Seeherunvong","year":"2011","unstructured":"Seeherunvong, W. & Wolf, M. Tertiary excess of fibroblast growth factor 23 and hypophosphataemia following kidney transplantation. Pediatr. Transplant. 15, 37\u201346 (2011).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph2015153_CR101","doi-asserted-by":"crossref","first-page":"e1000154","DOI":"10.1371\/journal.pgen.1000154","volume":"8","author":"D Sitara","year":"2008","unstructured":"Sitara, D. et al. Genetic evidence of serum phosphate-independent functions of FGF-23 on bone. PLoS Genet. 8, e1000154 (2008).","journal-title":"PLoS Genet."},{"key":"BFnrneph2015153_CR102","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1359\/jbmr.080220","volume":"23","author":"H Wang","year":"2008","unstructured":"Wang, H. et al. Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J. Bone Miner. Res. 23, 939\u2013948 (2008).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph2015153_CR103","first-page":"2096","volume":"10","author":"WH Grotz","year":"1995","unstructured":"Grotz, W. H. et al. Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients. Nephrol. Dial. Transplant. 10, 2096\u20132100 (1995).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR104","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000137287","volume":"31","author":"P Bubenicek","year":"2008","unstructured":"Bubenicek, P., Sotornik, I., Vitko, S. & Teplan, V. Early bone mineral density loss after renal transplantation and pre-transplant PTH: a prospective study. Kidney Blood Press. Res. 31, 196\u2013202 (2008).","journal-title":"Kidney Blood Press. Res."},{"key":"BFnrneph2015153_CR105","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/ndt\/17.7.1318","volume":"17","author":"JP Casez","year":"2002","unstructured":"Casez, J. P., Lippuner, K., Horber, F. F., Montandon, A. & Jaeger, P. Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone. Nephrol. Dial. Transplant. 17, 1318\u20131326 (2002).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR106","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/ajt.12911","volume":"14","author":"P Evenepoel","year":"2014","unstructured":"Evenepoel, P. et al. A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism. Am. J. Transplant. 14, 2545\u20132555 (2014).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2015153_CR107","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/TP.0b013e3182985468","volume":"96","author":"CL Neves","year":"2013","unstructured":"Neves, C. L. et al. Persistence of bone and mineral disorders 2 years after successful kidney transplantation. Transplantation 96, 290\u2013296 (2013).","journal-title":"Transplantation"},{"key":"BFnrneph2015153_CR108","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/kisup.2011.28","volume":"1","author":"J Bover","year":"2011","unstructured":"Bover, J. & Cozzolino, M. Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation. Kidney Int. Suppl. 1, 122\u2013129 (2011).","journal-title":"Kidney Int. Suppl."},{"key":"BFnrneph2015153_CR109","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI109359","volume":"63","author":"TL Chen","year":"1979","unstructured":"Chen, T. L. & Feldman, D. Glucocorticoid receptors and actions in subpopulations of cultured rat bone cells. Mechanism of dexamethasone potentiation of parathyroid hormone-stimulated cyclic AMP production. J. Clin. Invest. 63, 750\u2013758 (1979).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2015153_CR110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ndt\/11.supp3.58","volume":"11","author":"F Velasquez-Forero","year":"1996","unstructured":"Velasquez-Forero, F., Mondragon, A., Herrero, B. & Pena, J. C. Adynamic bone lesion in renal transplant recipients with normal renal function. Nephrol. Dial. Transplant. 11, 58\u201364 (1996).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR111","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am. J. Transplant. 9, S1\u2013155 (2009).","DOI":"10.1111\/j.1600-6143.2009.02834.x"},{"key":"BFnrneph2015153_CR112","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00467-009-1252-4","volume":"25","author":"K Sakhaee","year":"2010","unstructured":"Sakhaee, K. Post-renal transplantation hypophosphataemia. Pediatr. Nephrol. 25, 213\u2013220 (2010).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2015153_CR113","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1056\/NEJM200309043491020","volume":"349","author":"S Desmeules","year":"2003","unstructured":"Desmeules, S., Bergeron, M. J. & Isenring, P. Acute phosphate nephropathy and renal failure. N. Engl. J. Med. 349, 1006\u20131007 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2015153_CR114","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/01.TP.0000435596.88869.14","volume":"96","author":"N Singh","year":"2013","unstructured":"Singh, N. & Qadir, M. Do no harm: calcium and phosphate supplementation in kidney transplant recipients. Transplantation 96, e81\u2013e82 (2013).","journal-title":"Transplantation"},{"key":"BFnrneph2015153_CR115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJM199407073310122","volume":"331","author":"P Michaut","year":"1994","unstructured":"Michaut, P., Prie, D., Amiel, C. & Friedlander, G. Dipyridamole for renal phosphate leak? N. Engl. J. Med. 331, 58\u201359 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2015153_CR116","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1681\/ASN.V971264","volume":"9","author":"D Prie","year":"1998","unstructured":"Prie, D., Blanchet, F. B., Essig, M., Jourdain, J. P. & Friedlander, G. Dipyridamole decreases renal phosphate leak and augments serum phosphorus in patients with low renal phosphate threshold. J. Am. Soc. Nephrol. 9, 1264\u20131269 (1998).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR117","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5414\/CNP63087","volume":"63","author":"M Balal","year":"2005","unstructured":"Balal, M., Paydas, S., Seyrek, N., Sertdemir, Y. & Karayaylali, I. Dipyridamole for renal phosphate leak in successfully renal transplanted hypophosphatemic patients. Clin. Nephrol. 63, 87\u201391 (2005).","journal-title":"Clin. Nephrol."},{"key":"BFnrneph2015153_CR118","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1172\/JCI115960","volume":"90","author":"G Friedlander","year":"1992","unstructured":"Friedlander, G., Couette, S., Coureau, C. & Amiel, C. Mechanisms whereby extracellular adenosine 3\u2032,5\u2032-monophosphate inhibits phosphate transport in cultured opossum kidney cells and in rat kidney. Physiological implication. J. Clin. Invest. 90, 848\u2013858 (1992).","journal-title":"J. Clin. Invest."},{"key":"BFnrneph2015153_CR119","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl. 113, S1\u2013S130 (2009)."},{"key":"BFnrneph2015153_CR120","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2215\/CJN.06080809","volume":"5","author":"K Kalantar-Zadeh","year":"2010","unstructured":"Kalantar-Zadeh, K. et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 5, 519\u2013530 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR121","first-page":"49","volume":"109","author":"E Ritz","year":"2012","unstructured":"Ritz, E. et al. Phosphate additives in food\u2014a health risk. Dtsch. Arztebl. Int. 109, 49\u201355 (2012).","journal-title":"Dtsch. Arztebl. Int."},{"key":"BFnrneph2015153_CR122","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3945\/ajcn.114.102715","volume":"102","author":"LW Moore","year":"2015","unstructured":"Moore, L. W. et al. Association of dietary phosphate and serum phosphorus concentration by levels of kidney function. Am. J. Clin. Nutr. 102, 444\u2013453 (2015).","journal-title":"Am. J. Clin. Nutr."},{"key":"BFnrneph2015153_CR123","doi-asserted-by":"crossref","first-page":"e003733-2013-00","DOI":"10.1136\/bmjopen-2013-003733","volume":"3","author":"J Powles","year":"2013","unstructured":"Powles, J. et al. Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open 3, e003733-2013-003733 (2013).","journal-title":"BMJ Open"},{"key":"BFnrneph2015153_CR124","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","volume":"21","author":"SM Burnett","year":"2006","unstructured":"Burnett, S. M. et al. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J. Bone Miner. Res. 21, 1187\u20131196 (2006).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrneph2015153_CR125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.jrn.2013.09.001","volume":"24","author":"AY Adema","year":"2014","unstructured":"Adema, A. Y., de Borst, M. H., Ter Wee, P. M., Vervloet, M. G. & NIGRAM Consortium. Dietary and Pharmacological Modification of Fibroblast Growth Factor-23 in Chronic Kidney Disease. J. Ren. Nutr. 24, 143\u2013150 (2014).","journal-title":"J. Ren. Nutr."},{"key":"BFnrneph2015153_CR126","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.2009.96","volume":"301","author":"C Sullivan","year":"2009","unstructured":"Sullivan, C. et al. Effect of food additives on hyperphosphataemia among patients with end-stage renal disease: a randomized controlled trial. JAMA 301, 629\u2013635 (2009).","journal-title":"JAMA"},{"key":"BFnrneph2015153_CR127","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1079\/BJN19860031","volume":"55","author":"AS Sandberg","year":"1986","unstructured":"Sandberg, A. S., Andersson, H., Kivisto, B. & Sandstrom, B. Extrusion cooking of a high-fibre cereal product. 1. Effects on digestibility and absorption of protein, fat, starch, dietary fibre and phytate in the small intestine. Br. J. Nutr. 55, 245\u2013254 (1986).","journal-title":"Br. J. Nutr."},{"key":"BFnrneph2015153_CR128","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2215\/CJN.05040610","volume":"6","author":"SM Moe","year":"2011","unstructured":"Moe, S. M. et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 257\u2013264 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR129","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2215\/CJN.08601209","volume":"5","author":"N Noori","year":"2010","unstructured":"Noori, N. et al. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 5, 683\u2013692 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR130","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2215\/CJN.02830409","volume":"4","author":"RA Sherman","year":"2009","unstructured":"Sherman, R. A. & Mehta, O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin. J. Am. Soc. Nephrol. 4, 1370\u20131373 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7762\/cnr.2013.2.1.1","volume":"2","author":"MR Rho","year":"2013","unstructured":"Rho, M. R. et al. Evaluation of nutrient intake in early post kidney transplant recipients. Clin. Nutr. Res. 2, 1\u201311 (2013).","journal-title":"Clin. Nutr. Res."},{"key":"BFnrneph2015153_CR132","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2215\/CJN.05420709","volume":"5","author":"RB Oliveira","year":"2010","unstructured":"Oliveira, R. B. et al. Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clin. J. Am. Soc. Nephrol. 5, 286\u2013291 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR133","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1093\/ndt\/gfh446","volume":"19","author":"AK Pieper","year":"2004","unstructured":"Pieper, A. K. et al. The effect of sevelamer on the pharmacokinetics of cyclosporin A and mycophenolate mofetil after renal transplantation. Nephrol. Dial. Transplant. 19, 2630\u20132633 (2004).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR134","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MNH.0b013e32836214d4","volume":"22","author":"M Ketteler","year":"2013","unstructured":"Ketteler, M. & Biggar, P. H. Use of phosphate binders in chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 22, 413\u2013420 (2013).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"BFnrneph2015153_CR135","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ndt\/gfq419","volume":"26","author":"T Isakova","year":"2011","unstructured":"Isakova, T. et al. Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol. Dial. Transplant. 26, 584\u2013591 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR136","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.tp.0000230130.50451.78","volume":"82","author":"S Akaberi","year":"2006","unstructured":"Akaberi, S. et al. Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function. Transplantation 82, 749\u2013752 (2006).","journal-title":"Transplantation"},{"key":"BFnrneph2015153_CR137","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/ctr.12341","volume":"28","author":"IH Bleskestad","year":"2014","unstructured":"Bleskestad, I. H. et al. Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function. Clin. Transplant. 28, 479\u2013486 (2014).","journal-title":"Clin. Transplant."},{"key":"BFnrneph2015153_CR138","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ki.2008.549","volume":"75","author":"M Courbebaisse","year":"2009","unstructured":"Courbebaisse, M. et al. Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int. 75, 646\u2013651 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph2015153_CR139","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/ajt.12227","volume":"13","author":"H Amer","year":"2013","unstructured":"Amer, H. et al. Oral paricalcitol reduces the prevalence of posttransplant hyperparathyroidism: results of an open label randomized trial. Am. J. Transplant. 13, 1576\u20131585 (2013).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2015153_CR140","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1681\/ASN.2013111185","volume":"26","author":"M Trillini","year":"2014","unstructured":"Trillini, M. et al. Paricalcitol for secondary hyperparathyroidism in renal transplantation. J. Am. Soc. Nephrol. 26, 1205\u20131214 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR141","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2215\/CJN.07341009","volume":"5","author":"D Maccubbin","year":"2010","unstructured":"Maccubbin, D., Tipping, D., Kuznetsova, O., Hanlon, W. A. & Bostom, A. G. Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial. Clin. J. Am. Soc. Nephrol. 5, 582\u2013589 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR142","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/ndt\/gfh924","volume":"20","author":"AE Kruse","year":"2005","unstructured":"Kruse, A. E., Eisenberger, U., Frey, F. J. & Mohaupt, M. G. The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol. Dial. Transplant. 20, 1311\u20131314 (2005).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR143","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/ndt\/gfh925","volume":"20","author":"AL Serra","year":"2005","unstructured":"Serra, A. L., Schwarz, A. A., Wick, F. H., Marti, H. P. & Wuthrich, R. P. Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol. Dial. Transplant. 20, 1315\u20131319 (2005).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR144","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2215\/CJN.00500705","volume":"1","author":"TR Srinivas","year":"2006","unstructured":"Srinivas, T. R. et al. Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin. J. Am. Soc. Nephrol. 1, 323\u2013326 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2015153_CR145","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/01.tp.0000232452.80018.ad","volume":"82","author":"I Szwarc","year":"2006","unstructured":"Szwarc, I. et al. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Transplantation 82, 675\u2013680 (2006).","journal-title":"Transplantation"},{"key":"BFnrneph2015153_CR146","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/j.1600-6143.2006.01475.x","volume":"6","author":"N Leca","year":"2006","unstructured":"Leca, N. et al. Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet. Am. J. Transplant. 6, 2391\u20132395 (2006).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2015153_CR147","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ndt\/gfm632","volume":"23","author":"P Falck","year":"2008","unstructured":"Falck, P. et al. Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients. Nephrol. Dial. Transplant. 23, 1048\u20131053 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2015153_CR148","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000337526","volume":"35","author":"M Courbebaisse","year":"2012","unstructured":"Courbebaisse, M. et al. Effects of cinacalcet in renal transplant patients with hyperparathyroidism. Am. J. Nephrol. 35, 341\u2013348 (2012).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph2015153_CR149","first-page":"963","volume":"57","author":"JH Ix","year":"2011","unstructured":"Ix, J. H., Ganjoo, P., Tipping, D., Tershakovec, A. M. & Bostom, A. G. Sustained hypophosphatemic effect of once-daily niacin\/laropiprant in dyslipidemic CKD stage 3 patients. Am. J. Kidney Dis. 57, 963\u2013965 (2011).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2015153_CR150","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1681\/ASN.2014030317","volume":"26","author":"ED Labonte","year":"2015","unstructured":"Labonte, E. D. et al. Gastrointestinal inhibition of sodium-hydrogen exchanger 3 reduces phosphorus absorption and protects against vascular calcification in CKD. J. Am. Soc. Nephrol. 26, 1138\u20131149 (2015).","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.153","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2015.153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:46:09Z","timestamp":1684471569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2015.153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,29]]},"references-count":150,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFnrneph2015153"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2015.153","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,29]]},"assertion":[{"value":"29 September 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}